anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Analyze Data

Slide function collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 58,039
Current window 23,941-23,970
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all
18 30 60

Slide function

23,941-23,970 of 58,039

filter-aware
41
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
Includes a callout highlighting 35% organic revenue growth for Global Solta.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
The slide highlights a 6% decline in WELLBUTRIN/APLENZIN revenue as a key driver.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
The table compares Q1 2021 vs Q1 2020 performance with reported and constant currency variance metrics.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The table tracks quarterly revenue in millions of dollars for the top 10 products ranked by 1Q21 performance.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
The table tracks revenue in millions of dollars for the top 10 products, ranked by 1Q21 performance.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The table lists products by rank and provides quarterly revenue figures in millions of dollars.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
The table tracks revenue in millions of dollars for 10 products from 1Q20 to 1Q21.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
The table lists products by rank and provides revenue figures in millions of dollars for each of the last five quarters.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
The table lists products ranked by revenue in 1Q21, with historical data for the previous four quarters.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
The table details specific line items like amortization, impairments, and restructuring costs, showing their impact on both total income and EPS.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
Includes a callout box clarifying that corporate G&A and R&D are not allocated.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
54
Includes footnotes regarding segment reporting and estimates.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
55
The slide includes two distinct tables: one for Revenue and one for Adj. Segment Profit/EBITA. It also includes a disclaimer about G&A and R&D allocation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
56
The slide provides supplemental financial metrics including R&D, G&A, Depreciation, CapEx, and Stock-Based Compensation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
57
The table includes revenue, adjusted gross profit, adjusted gross margin, R&D, SG&A, and adjusted segment profit/EBITA.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
58
The table includes a mix of quarterly and annual data columns.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
59
The table includes a 'New Segment Structure' callout and detailed footnotes regarding non-GAAP adjustments and segment realignment.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
60
The table includes a mix of quarterly and annual data columns.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
61
The slide presents two separate tables for YTD 2021 and YTD 2020, detailing specific line-item adjustments.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
62
Includes footnotes regarding asset impairment definitions and segment reporting structure.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
63
The table reconciles GAAP to non-GAAP figures by adding back acquisition-related costs and adjustments.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
64
The slide provides a detailed breakdown of non-GAAP financial adjustments.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
65
This is a standard financial disclosure slide providing a bridge between GAAP and non-GAAP metrics.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
66
The table is split into two main sections: the left side calculates organic revenue for 2020/2019 periods, and the right side calculates organic revenue growth by comparing 2019/2018 periods.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
67
The table reconciles reported revenue to organic revenue by adjusting for exchange rates, divestitures, and discontinuations.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
68
The table is split into two main sections: one adjusting for exchange rates and one adjusting for divestitures/discontinuations, leading to a final organic growth calculation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
69
The table adjusts reported revenue for exchange rates and divestitures to arrive at organic revenue.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
70
The slide provides a bridge between GAAP and non-GAAP cash flow metrics by adding back specific legal and separation costs.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit